Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Access Industries subsidiary Access Biotechnology co-led a round disclosed by the radiopharmaceutical drug developer as it publicly launched.

Mercedes-Benz and Stellantis made strategic investments in advanced battery developer Factorial Energy while celluar therapy developer Mana Therapeutics closed its $42m series A round.

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Sonic Healthcare and I-Med Radiology Network helped the smart diagnostics technology developer secure $91.6m that will be used to accelerate its expansion into new medical areas and scale its team.

Merck & Co and SR One were among the investors in a series C round for the small molecule drug developer led by Pivotal BioVenture Partners.

The vaccine developer's series C-plus round was co-led by SoftBank Vision Fund and came just three months after it closed a $700m series C.

The Legend Holdings-formed venture capital firm is reportedly seeking $300m for the final close of its latest dollar-denominated healthcare vehicle.

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.